Search Results - "Michele, Kaup"

Phase II Study of Pentostatin in Patients With Corticosteroid-Refractory Chronic Graft-Versus-Host Disease by JACOBSOHN, David A, CHEN, Allen R, ZAHURAK, Marianna, PIANTADOSI, Steven, ANDERS, Viki, BOLANOS-MEADE, Javier, HIGMAN, Meghan, MARGOLIS, Jeffrey, KAUP, Michele, VOGELSANG, Georgia B

“…Therapy for patients with chronic graft-versus-host disease (cGVHD) is based on prolonged immunosuppression with corticosteroids. There is no standard therapy…”
Get full text

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide by Luznik, Leo, O'Donnell, Paul V, Symons, Heather J, Chen, Allen R, Leffell, M. Susan, Zahurak, Marianna, Gooley, Ted A, Piantadosi, Steve, Kaup, Michele, Ambinder, Richard F, Huff, Carol Ann, Matsui, William, Bolaños-Meade, Javier, Borrello, Ivan, Powell, Jonathan D, Harrington, Elizabeth, Warnock, Sandy, Flowers, Mary, Brodsky, Robert A, Sandmaier, Brenda M, Storb, Rainer F, Jones, Richard J, Fuchs, Ephraim J

“…Abstract We evaluated the safety and efficacy of high-dose, posttransplantation cyclophosphamide (Cy) to prevent graft rejection and graft-versus-host disease…”
Get full text

Post-Transplantation High Dose Cyclophosphamide (Cy) Is Effective Single Agent for Prevention of Acute and Chronic Graft Versus Host Disease after Myeloablative HLA Matched Related and Unrelated Bone Marrow Transplantation (BMT) by Luznik, Leo, Bolanos-Meade, Javier, Brodsky, Robert, Smith, B. Douglas, Huff, Carol A., Kaup, Michele, Chen, Allen, Ambinder, Richard F., Jones, Richard J., Fuchs, Ephraim J.

“…Based on our results in animal models and promising results in HLA-haploidentical setting (L. Luznik, Blood 2002 and BBMT 2008), we studied whether high dose…”
Get full text

Post-Transplantation High-Dose Cyclophosphamide (Cy) Is Effective Single Agent GVHD Prophylaxis That Permits Prompt Immune Reconstitution after Myeloablative HLA Matched Related and Unrelated Bone Marrow Transplantation (BMT) by Leo, Luznik, Allen, Chen R., Michele, Kaup, Emilie, Bright C., Javier, Bolanos-Meade, Christopher, Thorburn J., Ferdynand, Kos, Allan, Hess D., Richard, Jones J., Ephraim, Fuchs J.

“…Prolonged pharmacologic immunosuppression is a major obstacle to early immunologic recovery after allogeneic BMT. Based on our results in animal models, we…”
Get full text